Literature DB >> 3348855

Catechol-o-methyl transferase activity in the human term placenta.

E R Barnea1, N J MacLusky, A H DeCherney, F Naftolin.   

Abstract

Catechol-O-methyltransferase (COMT) characteristics and activity were studied using radioenzymatic techniques in placentas from normal and high-risk patients at term. The affinity of the catechol estrogen 20-hydroxyestrone (2OHE1), Km = 5 microM, for the enzyme was found to be at least 90-fold higher than that of the catecholamines norepinephrine, epinephrine, and dopamine (450, 490, and 850 microM, respectively). The product formed after incubation of placental cytosol with tritiated 20HE1 was identified as being exclusively (3H) 2-methoxyestrone, by use of high-performance liquid chromatography. Placental COMT activity after normal spontaneous delivery was no different from that obtained after elective cesarean section (270 +/- 20 versus 275 +/- 27, expressed as mean +/- SE activity nanomoles of 2-methoxyestrone formed per hour/mg protein). Placental COMT activity at term in women with hypertension (toxemia [T] or chronic hypertension [CHBP]) was significantly lower than in control subjects (284 +/- 27 versus 183 +/- 26; P less than 0.05). No significant differences in enzyme activity were found between T and CHBP (175 +/- 37 versus 210 +/- 32, P = NS). There were also no differences in COMT activity of diabetic classes A-R (White classification), fetal distress (with or without acidosis), and controls. The possible interference of antihypertensive drugs used by the patients in the study on COMT activity was assessed. Incubations of healthy placental cytosol with hydralazine, methyldopa, and Mg++ in their estimated plasma therapeutic concentrations had no effect on placental COMT activity. The present study suggests that placental COMT activity is low in patients with hypertension.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3348855     DOI: 10.1055/s-2007-999669

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  19 in total

1.  Elevated expression of catechol-O-methyltransferase is associated with labor and increased prostaglandin E(2) production by human fetal membranes.

Authors:  Hassan Harirah; Chandrasekhar Thota; Melissa J Wentz; Wahiduz Zaman; Ayman Al-Hendy
Journal:  Am J Obstet Gynecol       Date:  2009-08-07       Impact factor: 8.661

2.  Loss of placental growth factor ameliorates maternal hypertension and preeclampsia in mice.

Authors:  Jacqueline G Parchem; Keizo Kanasaki; Megumi Kanasaki; Hikaru Sugimoto; Liang Xie; Yuki Hamano; Soo Bong Lee; Vincent H Gattone; Samuel Parry; Jerome F Strauss; Vesna D Garovic; Thomas F McElrath; Karen H Lu; Baha M Sibai; Valerie S LeBleu; Peter Carmeliet; Raghu Kalluri
Journal:  J Clin Invest       Date:  2018-10-08       Impact factor: 14.808

3.  Regulation of catechol-O-methyltransferase expression in human myometrial cells.

Authors:  Melissa J Wentz; Mohammad Jamaluddin; Robert E Garfield; Ayman Al-Hendy
Journal:  Obstet Gynecol       Date:  2006-12       Impact factor: 7.661

4.  O-methylation of catechol estrogens by human placental catechol-o-methyltransferase: interindividual differences in sensitivity to heat inactivation and to inhibition by dietary polyphenols.

Authors:  Bao Ting Zhu; Karen Y Wu; Pan Wang; May Xiaoxin Cai; Allan H Conney
Journal:  Drug Metab Dispos       Date:  2010-07-06       Impact factor: 3.922

Review 5.  Metabolic pathways involved in 2-methoxyestradiol synthesis and their role in preeclampsia.

Authors:  Alejandra Perez-Sepulveda; Pedro P España-Perrot; Errol R Norwitz; Sebastián E Illanes
Journal:  Reprod Sci       Date:  2013-03-01       Impact factor: 3.060

6.  Preeclampsia: 2-methoxyestradiol induces cytotrophoblast invasion and vascular development specifically under hypoxic conditions.

Authors:  Soo Bong Lee; Amy P Wong; Keizo Kanasaki; Yong Xu; Vivek K Shenoy; Thomas F McElrath; George M Whitesides; Raghu Kalluri
Journal:  Am J Pathol       Date:  2010-01-14       Impact factor: 4.307

Review 7.  The biology of preeclampsia.

Authors:  Keizo Kanasaki; Raghu Kalluri
Journal:  Kidney Int       Date:  2009-08-05       Impact factor: 10.612

8.  2-methoxyestradiol plasma levels are associated with clinical severity indices and biomarkers of preeclampsia.

Authors:  Miriam Pertegal; Francisco J Fenoy; Barbara Bonacasa; Jaime Mendiola; Juan L Delgado; Moises Hernández; Miguel G Salom; Vicente Bosch; Isabel Hernández
Journal:  Reprod Sci       Date:  2014-06-04       Impact factor: 3.060

Review 9.  Placental ischemia and cardiovascular dysfunction in preeclampsia and beyond: making the connections.

Authors:  Jeffrey S Gilbert; Mark J Nijland; Penny Knoblich
Journal:  Expert Rev Cardiovasc Ther       Date:  2008-11

Review 10.  Pre-eclampsia: pathogenesis, novel diagnostics and therapies.

Authors:  Elizabeth A Phipps; Ravi Thadhani; Thomas Benzing; S Ananth Karumanchi
Journal:  Nat Rev Nephrol       Date:  2019-05       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.